カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界の医薬品用フルクトース市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Fructose for Pharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO3565）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO3565
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の医薬品用フルクトース市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

医薬品用フルクトース市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医薬品用フルクトースの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

医薬品用フルクトース市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・でんぷん加水分解、ショ糖加水分解

用途別セグメントは次のように区分されます。
・果糖注射剤、サプリメント、その他

世界の医薬品用フルクトース市場の主要な市場プレーヤーは以下のとおりです。
・Tate & Lyle、GALAM、DANISCO、Gadot Biochemical Industries、Xiwang Group、Guangdong Spring Young

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、医薬品用フルクトース製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用フルクトースメーカーの企業概要、2019年～2022年までの医薬品用フルクトースの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用フルクトースメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別医薬品用フルクトースの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの医薬品用フルクトースの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医薬品用フルクトース市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および医薬品用フルクトースの産業チェーンを掲載しています。
・第13、14、15章では、医薬品用フルクトースの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 医薬品用フルクトースの概要
- 種類別分析（2017年vs2021年vs2028年）：でんぷん加水分解、ショ糖加水分解
- 用途別分析（2017年vs2021年vs2028年）：果糖注射剤、サプリメント、その他
- 世界の医薬品用フルクトース市場規模・予測
- 世界の医薬品用フルクトース生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Tate & Lyle、GALAM、DANISCO、Gadot Biochemical Industries、Xiwang Group、Guangdong Spring Young
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：でんぷん加水分解、ショ糖加水分解
・用途別分析2017年-2028年：果糖注射剤、サプリメント、その他
・医薬品用フルクトースの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用フルクトースのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用フルクトースのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用フルクトースの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用フルクトースの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Fructose for Pharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fructose for Pharmaceutical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Fructose Injection accounting for % of the Fructose for Pharmaceutical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Starch Hydrolysis segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fructose for Pharmaceutical include Tate & Lyle, GALAM, DANISCO, Gadot Biochemical Industries, and Xiwang Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fructose for Pharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Starch Hydrolysis
Sucrose Hydrolysis
Market segment by Application can be divided into
Fructose Injection
Medical Supplements
Other
The key market players for global Fructose for Pharmaceutical market are listed below:
Tate & Lyle
GALAM
DANISCO
Gadot Biochemical Industries
Xiwang Group
Guangdong Spring Young
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fructose for Pharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fructose for Pharmaceutical, with price, sales, revenue and global market share of Fructose for Pharmaceutical from 2019 to 2022.
Chapter 3, the Fructose for Pharmaceutical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fructose for Pharmaceutical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fructose for Pharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fructose for Pharmaceutical.
Chapter 13, 14, and 15, to describe Fructose for Pharmaceutical sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Fructose for Pharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fructose for Pharmaceutical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Starch Hydrolysis
1.2.3 Sucrose Hydrolysis
1.3 Market Analysis by Application
1.3.1 Overview: Global Fructose for Pharmaceutical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Fructose Injection
1.3.3 Medical Supplements
1.3.4 Other
1.4 Global Fructose for Pharmaceutical Market Size & Forecast
1.4.1 Global Fructose for Pharmaceutical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fructose for Pharmaceutical Sales in Volume (2017-2028)
1.4.3 Global Fructose for Pharmaceutical Price (2017-2028)
1.5 Global Fructose for Pharmaceutical Production Capacity Analysis
1.5.1 Global Fructose for Pharmaceutical Total Production Capacity (2017-2028)
1.5.2 Global Fructose for Pharmaceutical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fructose for Pharmaceutical Market Drivers
1.6.2 Fructose for Pharmaceutical Market Restraints
1.6.3 Fructose for Pharmaceutical Trends Analysis
2 Manufacturers Profiles
2.1 Tate & Lyle
2.1.1 Tate & Lyle Details
2.1.2 Tate & Lyle Major Business
2.1.3 Tate & Lyle Fructose for Pharmaceutical Product and Services
2.1.4 Tate & Lyle Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GALAM
2.2.1 GALAM Details
2.2.2 GALAM Major Business
2.2.3 GALAM Fructose for Pharmaceutical Product and Services
2.2.4 GALAM Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 DANISCO
2.3.1 DANISCO Details
2.3.2 DANISCO Major Business
2.3.3 DANISCO Fructose for Pharmaceutical Product and Services
2.3.4 DANISCO Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Gadot Biochemical Industries
2.4.1 Gadot Biochemical Industries Details
2.4.2 Gadot Biochemical Industries Major Business
2.4.3 Gadot Biochemical Industries Fructose for Pharmaceutical Product and Services
2.4.4 Gadot Biochemical Industries Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xiwang Group
2.5.1 Xiwang Group Details
2.5.2 Xiwang Group Major Business
2.5.3 Xiwang Group Fructose for Pharmaceutical Product and Services
2.5.4 Xiwang Group Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Guangdong Spring Young
2.6.1 Guangdong Spring Young Details
2.6.2 Guangdong Spring Young Major Business
2.6.3 Guangdong Spring Young Fructose for Pharmaceutical Product and Services
2.6.4 Guangdong Spring Young Fructose for Pharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fructose for Pharmaceutical Breakdown Data by Manufacturer
3.1 Global Fructose for Pharmaceutical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fructose for Pharmaceutical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fructose for Pharmaceutical
3.4 Market Concentration Rate
3.4.1 Top 3 Fructose for Pharmaceutical Manufacturer Market Share in 2021
3.4.2 Top 6 Fructose for Pharmaceutical Manufacturer Market Share in 2021
3.5 Global Fructose for Pharmaceutical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fructose for Pharmaceutical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fructose for Pharmaceutical Market Size by Region
4.1.1 Global Fructose for Pharmaceutical Sales in Volume by Region (2017-2028)
4.1.2 Global Fructose for Pharmaceutical Revenue by Region (2017-2028)
4.2 North America Fructose for Pharmaceutical Revenue (2017-2028)
4.3 Europe Fructose for Pharmaceutical Revenue (2017-2028)
4.4 Asia-Pacific Fructose for Pharmaceutical Revenue (2017-2028)
4.5 South America Fructose for Pharmaceutical Revenue (2017-2028)
4.6 Middle East and Africa Fructose for Pharmaceutical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fructose for Pharmaceutical Sales in Volume by Type (2017-2028)
5.2 Global Fructose for Pharmaceutical Revenue by Type (2017-2028)
5.3 Global Fructose for Pharmaceutical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fructose for Pharmaceutical Sales in Volume by Application (2017-2028)
6.2 Global Fructose for Pharmaceutical Revenue by Application (2017-2028)
6.3 Global Fructose for Pharmaceutical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fructose for Pharmaceutical Sales by Type (2017-2028)
7.2 North America Fructose for Pharmaceutical Sales by Application (2017-2028)
7.3 North America Fructose for Pharmaceutical Market Size by Country
7.3.1 North America Fructose for Pharmaceutical Sales in Volume by Country (2017-2028)
7.3.2 North America Fructose for Pharmaceutical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fructose for Pharmaceutical Sales by Type (2017-2028)
8.2 Europe Fructose for Pharmaceutical Sales by Application (2017-2028)
8.3 Europe Fructose for Pharmaceutical Market Size by Country
8.3.1 Europe Fructose for Pharmaceutical Sales in Volume by Country (2017-2028)
8.3.2 Europe Fructose for Pharmaceutical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fructose for Pharmaceutical Sales by Type (2017-2028)
9.2 Asia-Pacific Fructose for Pharmaceutical Sales by Application (2017-2028)
9.3 Asia-Pacific Fructose for Pharmaceutical Market Size by Region
9.3.1 Asia-Pacific Fructose for Pharmaceutical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fructose for Pharmaceutical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fructose for Pharmaceutical Sales by Type (2017-2028)
10.2 South America Fructose for Pharmaceutical Sales by Application (2017-2028)
10.3 South America Fructose for Pharmaceutical Market Size by Country
10.3.1 South America Fructose for Pharmaceutical Sales in Volume by Country (2017-2028)
10.3.2 South America Fructose for Pharmaceutical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fructose for Pharmaceutical Sales by Type (2017-2028)
11.2 Middle East & Africa Fructose for Pharmaceutical Sales by Application (2017-2028)
11.3 Middle East & Africa Fructose for Pharmaceutical Market Size by Country
11.3.1 Middle East & Africa Fructose for Pharmaceutical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fructose for Pharmaceutical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fructose for Pharmaceutical and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fructose for Pharmaceutical
12.3 Fructose for Pharmaceutical Production Process
12.4 Fructose for Pharmaceutical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fructose for Pharmaceutical Typical Distributors
13.3 Fructose for Pharmaceutical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Fructose for Pharmaceutical Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fructose for Pharmaceutical Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Tate & Lyle Basic Information, Manufacturing Base and Competitors
Table 4. Tate & Lyle Major Business
Table 5. Tate & Lyle Fructose for Pharmaceutical Product and Services
Table 6. Tate & Lyle Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GALAM Basic Information, Manufacturing Base and Competitors
Table 8. GALAM Major Business
Table 9. GALAM Fructose for Pharmaceutical Product and Services
Table 10. GALAM Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. DANISCO Basic Information, Manufacturing Base and Competitors
Table 12. DANISCO Major Business
Table 13. DANISCO Fructose for Pharmaceutical Product and Services
Table 14. DANISCO Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Gadot Biochemical Industries Basic Information, Manufacturing Base and Competitors
Table 16. Gadot Biochemical Industries Major Business
Table 17. Gadot Biochemical Industries Fructose for Pharmaceutical Product and Services
Table 18. Gadot Biochemical Industries Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Xiwang Group Basic Information, Manufacturing Base and Competitors
Table 20. Xiwang Group Major Business
Table 21. Xiwang Group Fructose for Pharmaceutical Product and Services
Table 22. Xiwang Group Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Guangdong Spring Young Basic Information, Manufacturing Base and Competitors
Table 24. Guangdong Spring Young Major Business
Table 25. Guangdong Spring Young Fructose for Pharmaceutical Product and Services
Table 26. Guangdong Spring Young Fructose for Pharmaceutical Sales (Tons), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Fructose for Pharmaceutical Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 28. Global Fructose for Pharmaceutical Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Fructose for Pharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Fructose for Pharmaceutical Production Capacity by Company, (Tons): 2020 VS 2021
Table 31. Head Office and Fructose for Pharmaceutical Production Site of Key Manufacturer
Table 32. Fructose for Pharmaceutical New Entrant and Capacity Expansion Plans
Table 33. Fructose for Pharmaceutical Mergers & Acquisitions in the Past Five Years
Table 34. Global Fructose for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 35. Global Fructose for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 36. Global Fructose for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Fructose for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 39. Global Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 40. Global Fructose for Pharmaceutical Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Fructose for Pharmaceutical Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Fructose for Pharmaceutical Price by Type (2017-2022) & (US$/Ton)
Table 43. Global Fructose for Pharmaceutical Price by Type (2023-2028) & (US$/Ton)
Table 44. Global Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 45. Global Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 46. Global Fructose for Pharmaceutical Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Fructose for Pharmaceutical Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Fructose for Pharmaceutical Price by Application (2017-2022) & (US$/Ton)
Table 49. Global Fructose for Pharmaceutical Price by Application (2023-2028) & (US$/Ton)
Table 50. North America Fructose for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 51. North America Fructose for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 52. North America Fructose for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Fructose for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 55. North America Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 56. North America Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 57. North America Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 58. Europe Fructose for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 59. Europe Fructose for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 60. Europe Fructose for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Fructose for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 63. Europe Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 64. Europe Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 65. Europe Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 66. Asia-Pacific Fructose for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 67. Asia-Pacific Fructose for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 68. Asia-Pacific Fructose for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Fructose for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 71. Asia-Pacific Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 72. Asia-Pacific Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 73. Asia-Pacific Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 74. South America Fructose for Pharmaceutical Sales by Country (2017-2022) & (Tons)
Table 75. South America Fructose for Pharmaceutical Sales by Country (2023-2028) & (Tons)
Table 76. South America Fructose for Pharmaceutical Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Fructose for Pharmaceutical Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 79. South America Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 80. South America Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 81. South America Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 82. Middle East & Africa Fructose for Pharmaceutical Sales by Region (2017-2022) & (Tons)
Table 83. Middle East & Africa Fructose for Pharmaceutical Sales by Region (2023-2028) & (Tons)
Table 84. Middle East & Africa Fructose for Pharmaceutical Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Fructose for Pharmaceutical Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Fructose for Pharmaceutical Sales by Type (2017-2022) & (Tons)
Table 87. Middle East & Africa Fructose for Pharmaceutical Sales by Type (2023-2028) & (Tons)
Table 88. Middle East & Africa Fructose for Pharmaceutical Sales by Application (2017-2022) & (Tons)
Table 89. Middle East & Africa Fructose for Pharmaceutical Sales by Application (2023-2028) & (Tons)
Table 90. Fructose for Pharmaceutical Raw Material
Table 91. Key Manufacturers of Fructose for Pharmaceutical Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Fructose for Pharmaceutical Typical Distributors
Table 95. Fructose for Pharmaceutical Typical Customers
List of Figures
Figure 1. Fructose for Pharmaceutical Picture
Figure 2. Global Fructose for Pharmaceutical Revenue Market Share by Type in 2021
Figure 3. Starch Hydrolysis
Figure 4. Sucrose Hydrolysis
Figure 5. Global Fructose for Pharmaceutical Revenue Market Share by Application in 2021
Figure 6. Fructose Injection
Figure 7. Medical Supplements
Figure 8. Other
Figure 9. Global Fructose for Pharmaceutical Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global Fructose for Pharmaceutical Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Fructose for Pharmaceutical Sales (2017-2028) & (Tons)
Figure 12. Global Fructose for Pharmaceutical Price (2017-2028) & (US$/Ton)
Figure 13. Global Fructose for Pharmaceutical Production Capacity (2017-2028) & (Tons)
Figure 14. Global Fructose for Pharmaceutical Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Fructose for Pharmaceutical Market Drivers
Figure 16. Fructose for Pharmaceutical Market Restraints
Figure 17. Fructose for Pharmaceutical Market Trends
Figure 18. Global Fructose for Pharmaceutical Sales Market Share by Manufacturer in 2021
Figure 19. Global Fructose for Pharmaceutical Revenue Market Share by Manufacturer in 2021
Figure 20. Fructose for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Fructose for Pharmaceutical Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Fructose for Pharmaceutical Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Fructose for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 24. Global Fructose for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 25. North America Fructose for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 26. Europe Fructose for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Fructose for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 28. South America Fructose for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Fructose for Pharmaceutical Revenue (2017-2028) & (USD Million)
Figure 30. Global Fructose for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 31. Global Fructose for Pharmaceutical Revenue Market Share by Type (2017-2028)
Figure 32. Global Fructose for Pharmaceutical Price by Type (2017-2028) & (US$/Ton)
Figure 33. Global Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 34. Global Fructose for Pharmaceutical Revenue Market Share by Application (2017-2028)
Figure 35. Global Fructose for Pharmaceutical Price by Application (2017-2028) & (US$/Ton)
Figure 36. North America Fructose for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 37. North America Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 38. North America Fructose for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 39. North America Fructose for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 40. United States Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Fructose for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 44. Europe Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 45. Europe Fructose for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 46. Europe Fructose for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 47. Germany Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Fructose for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Fructose for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Fructose for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 56. China Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Fructose for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 63. South America Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 64. South America Fructose for Pharmaceutical Sales Market Share by Country (2017-2028)
Figure 65. South America Fructose for Pharmaceutical Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Fructose for Pharmaceutical Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Fructose for Pharmaceutical Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Fructose for Pharmaceutical Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Fructose for Pharmaceutical Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Fructose for Pharmaceutical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Fructose for Pharmaceutical in 2021
Figure 77. Manufacturing Process Analysis of Fructose for Pharmaceutical
Figure 78. Fructose for Pharmaceutical Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のフルクトースオリゴ糖市場2022年：市場規模予測（～2028年）
  • 世界の砂糖及び高果糖型コーンシロップ市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用デキストラン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用L-カルノシン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用ホスファチジルセリン市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO3565 )"世界の医薬品用フルクトース市場2022年：市場規模予測（～2028年）" (英文：Global Fructose for Pharmaceutical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。